tsRNA signatures in cancer
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Significance: We found that tRNA-derived small RNAs (tsRNAs) are dysregulated in many cancers and that their expression is modulated during cancer development and staging. Indeed, activation of oncogenes and inactivation of tumor suppressors lead to a dysregulation of specific tsRNAs, and tsRNA-KO cells display a specific change in gene-expression profile. Thus tsRNAs could be key effectors in cancer-related pathways. These results indicate active crosstalk between tsRNAs and oncogenes and suggest that tsRNAs could be useful markers for diagnosis or targets for therapy. Additionally,ts-46 and ts-47 affect cell growth in lung cancer cell lines, further confirming the involvement of tsRNAs in cancer pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Self-citationCalin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Self-citationGiancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Reich, M., Liefeld, T., Gould, J., Lerner, J., Tamayo, P., & Mesirov, J. P. (2006) · Nature Genetics · doi:10.1038/ng0506-500 · Cited by 2,032
PTEN and the PI3-Kinase Pathway in Cancer
Chalhoub, N., & Baker, S. J. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092311 · Cited by 1,245
A novel class of small RNAs: tRNA-derived RNA fragments (tRFs)
Lee, Y. S., Shibata, Y., Malhotra, A., & Dutta, A. (2009) · Genes & Development · doi:10.1101/gad.1837609 · Cited by 1,173
Angiogenin-Induced tRNA Fragments Inhibit Translation Initiation
Ivanov, P., Emara, M. M., Villen, J., Gygi, S. P., & Anderson, P. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.022 · Cited by 985
Sphingosine 1-phosphate and cancer
Pyne, N. J., & Pyne, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2875 · Cited by 852
The mTOR Signalling Pathway in Human Cancer
Pópulo, H., Lopes, J. M., & Soares, P. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021886 · Cited by 830
Human tRNA-derived small RNAs in the global regulation of RNA silencing
Haussecker, D., Huang, Y., Lau, A., Parameswaran, P., Fire, A. Z., & Kay, M. A. (2010) · RNA · doi:10.1261/rna.2000810 · Cited by 713
Cole, C., Sobala, A., Lu, C., Thatcher, S. R., Bowman, A., Brown, J. W. S., Green, P. J., Barton, G. J., & Hutvagner, G. (2009) · RNA · doi:10.1261/rna.1738409 · Cited by 645
Maute, R. L., Schneider, C., Sumazin, P., Holmes, A., Califano, A., Basso, K., & Dalla-Favera, R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206761110 · Cited by 615
Targeting the PDGF signaling pathway in tumor treatment
Heldin, C.-H. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-97 · Cited by 540
The interplay between Src and integrins in normal and tumor biology
Playford, M. P., & Schaller, M. D. (2004) · Oncogene · doi:10.1038/sj.onc.1208080 · Cited by 523
Angiogenin-induced tRNA-derived Stress-induced RNAs Promote Stress-induced Stress Granule Assembly
Emara, M. M., Ivanov, P., Hickman, T., Dawra, N., Tisdale, S., Kedersha, N., Hu, G.-F., & Anderson, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077560 · Cited by 500 · cited 1×
“tsRNAs are generated in the nucleus as a consequence of the pre-tRNA 3′ end cleavage (4), whereas tiRNAs are generated from mature tRNAs by cytoplasmic angiogenin activated in response to stress (6, 11).”
BackgroundPI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment
Guerrero-Zotano, A., Mayer, I. A., & Arteaga, C. L. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9637-x · Cited by 417
tRNA fragments in human health and disease
Anderson, P., & Ivanov, P. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.09.001 · Cited by 386
Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers
Honda, S., Loher, P., Shigematsu, M., Palazzo, J. P., Suzuki, R., Imoto, I., Rigoutsos, I., & Kirino, Y. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510077112 · Cited by 386
Liao, J.-Y., Ma, L.-M., Guo, Y.-H., Zhang, Y.-C., Zhou, H., Shao, P., Chen, Y.-Q., & Qu, L.-H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010563 · Cited by 307
Fabbri, M., Bottoni, A., Shimizu, M., Spizzo, R., Nicoloso, M. S., Rossi, S., Barbarotto, E., Cimmino, A., Adair, B., Wojcik, S. E., et al. (2011) · JAMA · doi:10.1001/jama.2010.1919 · Cited by 293
Self-citationControl of cell growth by c-Myc in the absence of cell division
Schuhmacher, M., Staege, M. S., Pajic, A., Polack, A., Weidle, U. H., Bornkamm, G. W., Eick, D., & Kohlhuber, F. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80507-7 · Cited by 288
Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer
Pekarsky, Y., Balatti, V., Palamarchuk, A., Rizzotto, L., Veneziano, D., Nigita, G., Rassenti, L. Z., Pass, H. I., Kipps, T. J., Liu, C.-G., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604266113 · Cited by 252
Self-citationMüller, S., Raulefs, S., Bruns, P., Afonso-Grunz, F., Plötner, A., Thermann, R., Jäger, C., Schlitter, A. M., Kong, B., Regel, I., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0358-5 · Cited by 250
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer
Zhao, D., Lu, X., Wang, G., Lan, Z., Liao, W., Li, J., Liang, X., Chen, J. R., Shah, S., Shang, X., et al. (2017) · Nature · doi:10.1038/nature21357 · Cited by 218
Cell cycle activation by c-myc in a Burkitt lymphoma model cell line
Pajic, A., Spitkovsky, D., Christoph, B., Kempkes, B., Schuhmacher, M., Staege, M. S., Brielmeier, M., Ellwart, J., Kohlhuber, F., Bornkamm, G. W., et al. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6<787::aid-ijc4>3.0.co;2-6 · Cited by 207
Müller, S., Raulefs, S., Bruns, P., Afonso-Grunz, F., Plötner, A., Thermann, R., Jäger, C., Schlitter, A. M., Kong, B., Regel, I., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0401-6 · Cited by 204
Ceramide Recruits and Activates Protein Kinase C ζ (PKCζ) within Structured Membrane Microdomains
Fox, T. E., Houck, K. L., O'Neill, S. M., Nagarajan, M., Stover, T. C., Pomianowski, P. T., Unal, O., Yun, J. K., Naides, S. J., & Kester, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700082200 · Cited by 185
Stoica, B. A., Movsesyan, V. A., Lea IV, P. M., & Faden, A. I. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(02)00028-3 · Cited by 160
Transcription termination by the eukaryotic RNA polymerase III
Arimbasseri, G. A., Rijal, K., & Maraia, R. J. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.10.006 · Cited by 134
3′ processing of eukaryotic precursor tRNAs
Maraia, R. J., & Lamichhane, T. N. (2011) · WIREs RNA · doi:10.1002/wrna.64 · Cited by 131
Zhang, X., He, X., Liu, C., Liu, J., Hu, Q., Pan, T. S., Duan, X., Liu, B., Zhang, Y., Chen, J., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1500805 · Cited by 129
Self-citationWillard, S. S., & Koochekpour, S. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.6475 · Cited by 100
Selitsky, S. R., & Sethupathy, P. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0800-0 · Cited by 95
Ceramide signaling in cancer and stem cells
Bieberich, E. (2008) · Future Lipidology · doi:10.2217/17460875.3.3.273 · Cited by 87
TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia
Balatti, V., Rizzotto, L., Miller, C. R., Palamarchuk, A., Fadda, P., Pandolfo, R., Rassenti, L. Z., Hertlein, E. K., Ruppert, A. S., Lozanski, A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500010112 · Cited by 83
Self-citationYu, G., Zhou, A., Xue, J., Huang, C., Zhang, X., Kang, S.-H., Chiu, W., Tan, C. Y. R., Xie, K., Wang, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3596 · Cited by 60
Sawai, H., Okada, Y., Funahashi, H., Matsuo, Y., Takahashi, H., Takeyama, H., & Manabe, T. (2005) · Oncogene · doi:10.1038/sj.onc.1209356 · Cited by 59
He, E., Pan, F., Li, G., & Li, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126149 · Cited by 58
Genetic polymorphisms ofmTORand cancer risk: a systematic review and updated meta-analysis
Zining, J., Xu, L., He, C., & Yuan, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10805 · Cited by 42
Henry, R. E., Barry, E. R., Castriotta, L., Ladd, B., Markovets, A., Beran, G., Ren, Y., Zhou, F., Adam, A., Zinda, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10859 · Cited by 37
Cited by
Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis
Zhu, L., Li, J., Gong, Y., Wu, Q., Tan, S., Sun, D., Xu, X., Zuo, Y., Zhao, Y., Wei, Y.-Q., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1000-8 · Cited by 339
Action mechanisms and research methods of tRNA-derived small RNAs
Xie, Y., Yao, L., Yu, X., Ruan, Y., Li, Z., & Guo, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00217-4 · Cited by 288
tRNA-derived fragments and tRNA halves: The new players in cancers
Zhu, L., Ge, J., Li, T., Shen, Y., & Guo, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.012 · Cited by 256
Noncanonical Roles of tRNAs: tRNA Fragments and Beyond
Su, Z., Wilson, B., Kumar, P., & Dutta, A. (2020) · Annual Review of Genetics · doi:10.1146/annurev-genet-022620-101840 · Cited by 235
“In addition, tRF-1s have been profiled by custom microarray with patient samples in CLL (chronic lymphocytic leukemia), lung, colon, ovary and breast cancer (2).”
BackgroundtRNA-derived RNA fragments in cancer: current status and future perspectives
Yu, M., Lu, B., Zhang, J., Ding, J., Liu, P., & Lu, Y. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00955-6 · Cited by 185
Metadata
- Authors
- Balatti, V., Nigita, G., Veneziano, D., Drusco, A., Stein, G. S., Messier, T. L., Farina, N. H., Lian, J. B., Tomasello, L., Liu, C.-G., Palamarchuk, A., Hart, J. R., Bell, C., Carosi, M., Pescarmona, E., Perracchio, L., Diodoro, M., Russo, A., Antenucci, A., Visca, P., Ciardi, A., Harris, C. C., Vogt, P. K., Pekarsky, Y., & Croce, C. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2017-07-10
- Volume
- 114
- Issue
- 30
- Pages
- 8071-8076
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2734686459
- Cited by
- 283
- References
- 43
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.